Co-Treatment of Suberoylanilide Hydroxamic Acid and Mitomycin-C Induces the Apoptosis of Rabbit Tenon's Capsule Fibroblast and Improves the Outcome of Glaucoma Filtration Surgery

REFERENCES

• Teng C C, Chi H H, Katzin H M. Histology and mechanism of filtering operations. Am J Ophthalmol. 1959; 47: 16–33
   PubMed Web of Science ®Google Scholar
• Halger M, Chevez-Barrios P, Lieberman M W, et al. Decorin and suramine inhibit ocular fibroblast collagen production. Graefe's Arch Clin Exp Ophthalmol. 1997; 235: 399–403
   Google Scholar
• Tilleul P, Denis P, Maignen F, et al. Effects of different formulations of mitoxantrone (solutions, nanospheres, liposomes) in glaucoma surgery rabbits. Ophthalmol Res. 1997; 29: 218–226
   PubMed Web of Science ®Google Scholar
• Addicks E M, Quigley H A, Green W R, Robin A L. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983; 101: 795–798
   PubMedGoogle Scholar
• Herschler J, Claflin A J, Fiorentino G. The effect of aqueous humor on the growth of subconjunctival fibroblasts in tissue culture and its implications for glaucoma surgery. Am J Ophthalmol. 1980; 89: 245–249
   PubMed Web of Science ®Google Scholar
• Tahery M M, Lee D A. Pharmacologic control of wound healing in glaucoma filtration surgery. J Ocul Pharmacol. 1989; 5: 155–179
   PubMedGoogle Scholar
• Esson D W, Neelakantam A, Iyer S A, et al. Expression of connective tissue growth factor after glaucoma filtration surgery in a rabbit model. Invest Ophthalmol Vis Sci 2004; 45: 485–491
   PubMed Web of Science ®Google Scholar
• Chen C W. Enhanced intraocular pressure controlling effectiveness of trabeculectomy results by local application of mitomycin C. Trans Asia Pac Acad Ophthalmol. 1983; 9: 172–177
   Google Scholar
• Matsuda T, Tanihara H, Hangai M, et al. Surgical results and complications of trabeculectomy with intraoperative application of mitomycin C. Jpn J Ophthalmol. 1996; 40: 526–532
   Google Scholar
• Singh J, O'Brien C, Chawla H B. Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye. 1995; 9: 460–466
   PubMedGoogle Scholar
• Derick R J, Pasquale L, Quigley H A, Jampel H. Potential toxicity of mitomycin C. Arch Ophthalmol 1991; 109: 1635
   PubMed Web of Science ®Google Scholar
• Schraermeyer U, Diestelhorst M, Bieker A, et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 539–600
   Google Scholar
• Sherwood M B. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006; 104: 478–492
   PubMedGoogle Scholar
• Franks W A, Hitchings R A. Complication of 5-fluorouracil after trabeculectomy. Eye. 1991; 5: 385–389
   PubMedGoogle Scholar
• Weinreb R N. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Opthalmology. 1987; 94: 564–570
   PubMed Web of Science ®Google Scholar
• Iizuka M, Smith M M. Functional consequences of histone modifications. Curr Opin Genet Dev 2003; 13: 154–160
   PubMed Web of Science ®Google Scholar
• Kim M S, Kwon H J, Lee Y M, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med. 2001; 7: 437–443
   PubMed Web of Science ®Google Scholar
• Marks P A, Richon V M, Rifkind R A. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst. 2000; 92: 1210–1216
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Marks P A. Prospects: Histone deacetylase inhibitors. J Cell Biochem. 2005; 96: 293–304
   PubMed Web of Science ®Google Scholar
• Cohen L A, Amin S, Marks P A, et al. Chemoprevention of carcinogen induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (Saha). Anticancer Res. 1999; 19: 4999–5005
   PubMed Web of Science ®Google Scholar
• Cress W D, Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol. 2000; 184: 1–16
   PubMed Web of Science ®Google Scholar
• Marks P A, Richon V M, Breslow R, Rifkind R A. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol. 2001; 13: 477–483
   PubMed Web of Science ®Google Scholar
• Johnstone R W, Licht J D. Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?. Cancer Cell 2003; 4: 13–18
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Oshima Y, Sakamoto M, et al. Electroporation and bleomycin in glaucoma filtering surgery. Invest Ophthalmol Vis Sci. 1997; 38: 2864–2868
   Google Scholar
• Avila M, Ortiz G, Lozano J M, et al. Effects of Rgd (Arg-Gly-Asp) peptides on glaucoma filtration surgery in rabbits. Ophthalmic Surg Laser 1998; 29: 309–317
   Google Scholar
• Jampel H, Moon J. The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. J Glaucoma. 1998; 7: 170–177
   Google Scholar
• Gillies M C, Goldberg I, Young S. Glaucoma filtering surgery interferon alpha 2b. J Glaucoma. 1993; 2: 229–235
   Google Scholar
• Al-Aswad L A, Huanng M, Netland P A. Inhibition of Tenon's fibroblast proliferation and enhancement of filtration surgery in rabbits with cytosine arabiniside. J Ocul Pharm Ther 1999; 15: 41–49
   Google Scholar
• Hueber A, Welsandt G, Jordan J F, et al. Chracterization of Cd95 ligand (Cd95L)-induced apoptosis in human Tenon fibroblast. Exp Eye Res. 2002; 75: 1–8
   Google Scholar
• Cristofanilli M, Pescosolido N, Risuleo G, Scarsella G. A murine cell culture model for post-trabeculectomy antifibrotic treatment: Induction of apoptosis by cyclosporin. Acta Ophthalmol Scand. 2001; 79: 309–312
   Google Scholar
• Constable P H, Crowston J G, Occleston N L, Khaw P T. The effects of single doses of β radiation on the wound healing behaviour of human Tenon's capsule fibroblasts. Br J Ophthalmol. 2004; 88: 169–173
   Google Scholar
• Siriwardena D, Khaw P T, King A J, et al. Human antitransforming growth factor β 2 monoclonal antibody—A new modulator of wound healing in trabeculectomy. Ophthalmology. 2002; 109: 427–431
   PubMed Web of Science ®Google Scholar
• Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem. 1987; 262: 5592–5595
   PubMed Web of Science ®Google Scholar
• Yu C, Rahmani M, Conrad D, et al. The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to Sti571. Blood. 2003; 102: 3765–3774
   PubMed Web of Science ®Google Scholar
• Bolden J E, Peart M J, Johnstone R W. Anticancer activities of histone deacetylase inhibitors. Nat Retv Drug Discov. 2006; 5: 769–784
   PubMed Web of Science ®Google Scholar
• Mitsiades C S, Poulaki V, McMullan C, et al. Novel histone deacetylase inhibitors in the treatment of thyroid cancer. Clin Cancer Res. 2005; 11: 3958–3965
   PubMed Web of Science ®Google Scholar
• Sonnemann J, Hartwig M, Plath A, et al. Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells. Cancer Lett. 2006; 232: 148–160
   Google Scholar
• Mei S, Ho A D, Mahlknecht U. Role of histone deacetylase inhibitors in the treatment of cancer. Int J Oncol. 2004; 25: 1509–1519
   PubMed Web of Science ®Google Scholar
• Roh M S, Kim C W, Park B S, et al. Trichostatin A induces apoptosis on human osteosarcoma cells in histone acetylation- and mitochondria-dependent fashions. Apoptosis. 2004; 9: 583–589
   PubMed Web of Science ®Google Scholar
• Zhang X D, Gillespie S K, Borrow J M, Hersey P. The histone deacetylase inhibitor suberic bishydroxamate: A potential sensitizer of melanoma to Tnf-related apoptosis-inducing ligand (Trail) induced apoptosis. Biochem Pharmacol. 2003; 66: 1537–1545
   PubMedGoogle Scholar
• Marks P A. Discovery and development of Saha as an anticancer agent. Oncogene. 2007; 26: 1351–1356
   PubMed Web of Science ®Google Scholar
• Skuta G L, Parish R K. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987; 32: 149–170
   PubMed Web of Science ®Google Scholar
• Miller M H, Grierson I, Unger W I, Hitchings R A. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg. 1989; 20: 350–357
   PubMedGoogle Scholar
• Miller M H, Joseph N H, Ennis K W, et al. An animal model of filtration surgery. Trans Ophthalmol Soc Uk. 1985; 104: 893–897
   PubMedGoogle Scholar